Dongxu Ke

Dr. Dongxu Ke

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications


28 July 2020 in Biofabrication
Verified
Journal Article
Closed access
LXLei Xu
Lei Xu
MVMathew Varkey
Mathew Varkey
AJAdam M Jorgensen
Adam M Jorgensen
JJJihui Ju
Jihui Ju
QJQianheng Jin
Qianheng Jin
AAAnthony Atala
Anthony Atala
Bioengineered artificial blood vessels have been a major area of interest over the last decade. Of particular interest are small diameter vessels, as surgical options are currently limited. This study aimed to fabricate a small diameter, heterogeneous bilayer blood vessel-like construct in a single step with gelatin methacryloyl (GelMA) bioink using a 3D micro-extrusion bioprinter on a solid platform. GelMA was supplemented with Hyaluronic acid (HA), glycerol and gelatin to form a GelMA bioink with good printability, mechanical strength, and biocompatibility. Two separate concentrations of GelMA bioink with unique pore sizes were selected to fabricate a heterogeneous bilayer. A higher concentration of GelMA bioink (6% w/v GelMA, 2% gelatin, 0.3% w/v HA, 10% v/v glycerol) was used to load human umbilical vein endothelial cells (HUVECs) and form an inner, endothelial tissue layer. A lower concentration of GelMA bioink (4% w/v GelMA, 4% gelatin, 0.3% w/v HA, 10% v/v glycerol) was used to load smooth muscle cells (SMCs) and form an outer, muscular tissue layer. Bioprinted blood vessel-like grafts were then assessed for mechanical properties with Instron mechanical testing, and suture-ability, and for biological properties including viability, proliferation, and histological analysis. The resulting 20 mm long, 4.0 mm diameter lumen heterogeneous bilayer blood vessel-like construct closely mimics a native blood vessel and maintains high cell viability and proliferation. Our results represent a novel strategy for small diameter blood vessel biofabrication.

31 December 2019 in Biofabrication
Verified
Journal Article
Closed access
PDF file
DKDongxu Ke
Dongxu Ke
HYHualin Yi
Hualin Yi
SESavannah Est-Witte
Savannah Est-Witte
SGSunil K George
Sunil K George
CKCarlos Kengla
Carlos Kengla
Sean MurphySean Murphy
Sean Murphy
Tracheal stenosis is a rare but life-threatening disease. Primary clinical procedures for treating this disease are limited if the region requiring repair is long or complex. This study is the first of its kind to fabricate bioprinted tracheal constructs with separate cartilage and smooth muscle regions using polycaprolactone (PCL) and human mesenchymal stem cell (hMSC)-laden hydrogels. Our final bioprinted trachea showed comparable elastic modulus and yield stress compared to native tracheal tissue. In addition, both cartilage and smooth muscle formation were observed in the desired regions of our bioprinted trachea through immunohistochemistry and western blot after two weeks of in vitro culture. This study demonstrates a novel approach to manufacture tissue engineered trachea with mechanical and biological properties similar to native trachea, which represents a step closer to overcoming the clinical challenges of treating tracheal stenosis.

15 July 2020 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
SBSusmita Bose
Susmita Bose
DKDongxu Ke
Dongxu Ke
AVAshley A. Vu
Ashley A. Vu
Amit BandyopadhyayAmit Bandyopadhyay
Amit Bandyopadhyay
Stuart B GoodmanStuart B Goodman
Stuart B Goodman

13 January 2022 in Bioprinting
Verified
Journal Article
Closed access
DKDongxu Ke
Dongxu Ke
CNChangmei Niu
Changmei Niu
XYXi Yang
Xi Yang